Loading clinical trials...
Loading clinical trials...
To date, more than 300 patients have been treated with Glofitamab in the Expanded Access Programme (EAP) in France. In this study, it is proposed to perform a retrospective analysis of some of these p...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Lymphoma Academic Research Organisation
NCT06788964 · Relapsed or Refractory Large B-cell Lymphoma
NCT04889716 · Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma
NCT06395103 · B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, and more
NCT05672251 · Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 3b Follicular Lymphoma, and more
NCT07200375 · Diffuse Large B-Cell Lymphoma
CH Victor Dupouy
Argenteuil
CH d'Avignon - Hôpital Henri Dufaut
Avignon
CH de la Côte Basque
Bayonne
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions